Home/MaaT Pharma/Frédéric Fasano
FF

Frédéric Fasano

Chief Strategy & Corporate Development Officer

MaaT Pharma

Therapeutic Areas

MaaT Pharma Pipeline

DrugIndicationPhase
MaaT013Acute Graft-versus-Host Disease (aGvHD)Phase 3
MaaT033Supportive care in Hemato-OncologyPhase 2
MaaT03XSolid Tumors (with ICI)Research